According to the recent study of Lacoste et al.[76] (see above), the attribution to the intracellular NIS fraction of a role in tumor cell locomotion may have important implications for those tumors expressing NIS in the cytoplasmic compartment, allowing use as a biomarker of aggressiveness. Here, SLC5A5 is linked to neoplasm.